|
|
|
 |
FDA Approval Activities for this Drug…
Robinul Forte (glycopyrrolate) Tablets, First Horizon Pharmaceutical NDA 12-827/S-049 7/25/03 8/6/03 | Robinul & Robinul Forte (glycopyrrolate) Tablets, First Horizon Pharmaceutical NDA 17-558/S-049 7/25/03 | Robinul (glycopyrrolate) Injectable, Baxter Healthcare NDA 17-558/S-047, S-048 GLYCOPYRROLATE Injection 0.2MG/ML ROBINUL Baxter CORP 089335 GLYCOPYRROLATE Injection 0.2MG/ML GLYCOPYRROLATE LUITPOLD | 012827 GLYCOPYRROLATE Tablet; 1MG ROBINUL FIRST HORIZON | 012827 GLYCOPYRROLATE Tablet; 2MG ROBINUL FORTE FIRST HORIZON | Robinul (glycopyrrolate for injection, USP) Injection, Baxter Healthcare, Labeling Revision | Glycopyrrolate Tablets, CorePharma, Approval | Robinul (glycopyrrolate) Injection, Baxter Healthcare, Labeling Revision | Glycopyrrolate Tablets, Kali Laboratories, Approval | Glycopyrrolate Tablets, Indicus Pharma, Approval | Glycopyrrolate Tablets, Vintage Pharmaceuticals, Approval | Glycopyrrolate Tablets, West-ward Pharmaceutical Corp., Approval | Glycopyrrolate Tablets, Ranbaxy Laboratories Ltd., Approval | Cuvposa (glycopyrrolate) Oral Solution, Shionogi Pharma, Inc., Approval | Glycopyrrolate Injection, Hikma Farmaceutica, Approval | Glycopyrrolate Tablets, Boca Pharmacal, Inc., Approval
  
|